In an investigation comparing individuals diagnosed with PPMS and SPMS during remission phases to healthy subjects, Plantone and colleagues observed that the higher percentage of peripheral perforin-expressing CD56dim NK cells in PPMS and SPMS cases indicates that they may contribute to developing these MS forms. This evidence concerns the gene PRF1 and myeloid sarcoma.